SCHEMBL25857312

SCHEMBL25857312

Cc1cc(F)cc2c(C3CCC(=O)NC3=O)nn(C)c12

nearest known ligand 0.57

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 20/20 0.57
CRBN Q96SW2 20/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25594936 0.85 DDB1 (0.54) DDB1CRBN
SCHEMBL25566828 0.85 DDB1 (0.54) DDB1CRBN
SCHEMBL25566694 0.85 DDB1 (0.54) DDB1CRBN
SCHEMBL25566827 0.85 DDB1 (0.54) DDB1CRBN
SCHEMBL25567336 0.81 DDB1 (0.64) DDB1CRBN
SCHEMBL25027088 0.81 DDB1 (0.77) DDB1CRBN
SCHEMBL25595582 0.81 DDB1 (0.60) DDB1CRBN
SCHEMBL25566760 0.81 DDB1 (0.77) DDB1CRBN
SCHEMBL25566824 0.79 DDB1 (0.64) DDB1CRBN
SCHEMBL25566763 0.77 DDB1 (0.43) DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023131167-A1 COMPOUND FOR INHIBITING AND DEGRADING IRAK4, AND PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL APPLICATION THEREOF 海思科医药集团股份有限公司 2023-07-13 WO disclosed